Sony Biotechnology Inc. Sony Biotechnology Inc.cart
About Us Products What's New Library News Calendar Contact Us Place Order
Safety Data Sheet (SDS) PerCP/Cy55 Anti-mouse CD197 CCR7 Antibody     Product Data Sheet (PDF)    
PerCP/Cy5.5 Anti-mouse CD197 (CCR7) Antibody
1200575 25 µg $120.00       
1200580 100 µg $270.00       
Clone: 4B12
Isotype: Rat IgG2a, κ
Reactivity: Mouse
Immunogen: Mouse CCR7 transfected RBL-2H3 cells
Formulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation: The antibody was purified by affinity chromatography, and conjugated with PerCP/Cy5.5 under optimal conditions. The solution is free of unconjugated PerCP/Cy5.5 and unconjugated antibody.
Concentration: 0.2 mg/ml
Storage & Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application:

FC - Quality tested

Application Notes:

The 4B12 antibody does not inhibit binding of ligand to receptor. Additional reported applications (for the relevant formats) include: immunoprecipitation. To reduce non-specific binding to cells bearing Fc-receptors, pre-incubation of cells with anti-mouse CD16/CD32, clone 93 is recommended prior to immunofluorescent staining.html" target="_blank">(see supplemental data of PE staining at differing temperatures).

Recommended Usage:

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 2.0 µg per 106cells in 100 µl staining volume. It is recommended that the reagent be titrated for optimal performance for each application.

* PerCP/Cy5.5 has a maximum absorption of 482 nm and a maximum emission of 690 nm.

Application References:

1. Ohl L, et al. 2004. Immunity 21:279.
2. Ritter U, et al. 2004. J. Leukocyte Biol. 76:472.
3. Lan YY, et al. 2005. Am. J. Transplant. 5:2649. (FC)
4. Lee JH, et al. 2007. J. Immunol. 178:301. (FC) PubMed
5. Kurooka M and Kaneda Y. 2007. Cancer Res. 67:227. (FC) PubMed
6. Thompson BD. 2007. J. Biol. Chem. 282:9547. (FC)
7. Sakai N, et al. 2006. P. Natl. Acad. Sci. USA 103:14098. (FC)
8. Turnquist HR, et al. 2007. J. Immunol. 178:7018. (FC)
9. Hwang IY, et al. 2007. J. Immunol. 179:439. (FC) PubMed
10. Kang SG, et al. 2007. J. Immunol. 179:3724.
11. Mao A et al. 2005. J. Immunol. 175:5146. PubMed
12. Allende ML, et al. 2008. FASEB J. 22:307. PubMed
13. Kang SG, et al. 2007. J. Immunol. 179:3724. PubMed
14. Chen H, et al. 2005. J. Immunol. 175:591. PubMed
15. Florido M, et al. 2009. Immunobiology. 214:643. PubMed
16. Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
17. del Rio ML, et al. 2011. Transpl. Int. 24:501. (FC) PubMed
18. Havenith SH, et al. 2014. Int Immunol. 26:183. PubMed
19. Goode D, et al. 2014. PLoS Pathog. 10:1004567. PubMed

C57BL/6 mouse splenocytes stained with

C57BL/6 mouse splenocytes stained with CD3 (17A2) FITC and 4B12 PerCP/Cy5.5



Description:

CD197 is also known as C-C chemokine receptor 7 (CCR7) or EBI-1. CCR7 is a G-coupled rhodopsin-like member of the GPCR superfamily with a predicted molecular weight of 43 kD that is expressed on hematopoietic stem cells, most naive T cells, some memory T cells, B subset, and mature dendritic cells. CCR7 is a receptor for the chemokines CCL19 (MIP3 beta) and SLC (6CKine, Exodus-2, TCA-4, CCL21) that plays a role in thymocytes development, T cell adhesion at intestinal sites, the homeostatic recirculation of memory T cells, and chemotaxis.

Other Names: C-C chemokine receptor type 7 (CCR7), MIP-3 beta receptor, EBV-induced G protein coupled receptor 1, EBI-1, CD197
Structure: Rhodopsin-like GPCR superfamily, G-protein coupled receptor 1 family, integral membrane protein, predicted molecular weight 43 kD
Distribution: Hematopoietic stem cells, T subsets, mature dendritic cells
Function: Homozygous mutation. Receptor for MIP-3 beta and SLC chemokines. Probable mediator of EBV effects on B lymphocytes. Plays a role in T cell adhesion at intestinal sites; may also play a role in the homeostatic recirculation of memory T cells and chemotaxis.
Ligand Receptor: MIP3 beta, SLC (6CKine, Exodus-2, TCA-4)
Antigen References:

1. Schweickart VL, et al. 1994. Genomics 23:643.
2. Yoshida R, et al. 1998. J. Biol. Chem. 273:7118.
3. Campbell JJ, et al. 1998. J. Cell Biol. 141:1053.
4. Willimann K, et al. 1998. Eur. J. Immunol. 28:2025.


This product or portions thereof is manufactured under license from GE Healthcare under U.S. Patent Numbers 5,268,486; 5,569,587; 5,627,027 and patents or pending applications that are continuations, continuations-in-part, re-examinations, divisionals, reissues or foreign equivalents thereof. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF GE HEALTHCARE BIO-SCIENCES CORP. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM GE HEALTHCARE BIO-SCIENCES CORP. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE.
COMMERCIAL USE shall include:

  • sale, lease, license or other transfer of the material or any material derived or produced from it;
  • sale, lease, license or other grant of rights to use this Material or any material derived or produced from it;
  • use of this material to perform services for a fee for third parties.

IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE RETURN THIS MATERIAL, UNOPENED TO Sony Biotechnology Inc., 2100 South Oak Street, Champaign, IL 61820, USA AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED.